The pharmaceutical and healthcare industry has yet to settle on a model for handling 340B product under the new DSCSA electronic data exchange mandate. With more than $53 billion in covered drugs purchased annually via the program, this poses a big challenge for the industry.
This on-demand webinar explores different approaches for managing 340B shipments. You’ll get insight from TraceLink’s traceability and compliance experts into:
- How new DSCSA mandates impact 340B receiving workflows at contract pharmacies.
- How to eliminate logistical friction between wholesalers and contract pharmacies.
- How to streamline the electronic data exchange process for a fully serialized world.
The DSCSA stabilization period ends soon! Watch this webinar to ensure you’ll be ready to handle 340B product.
TraceLink’s network platform, with Integrate Once, Interoperate with Everyone™ capability, revolutionizes compliance and operational efficiency for dispensing customers. By seamlessly connecting with an expansive digital network of supply chain partners, TraceLink ensures robust compliance with the Drug Supply Chain Security Act (DSCSA), swiftly manages compliance exceptions, and enables streamlined digital recalls. Furthermore, its advanced analytics capabilities facilitate the prediction of drug shortages, enhancing supply chain resilience. This integration offers pharmacies, hospitals, and other dispensers a comprehensive solution that not only meets regulatory demands but also optimizes inventory management and maintains the integrity of the drug supply, ensuring patient safety and continuity of care.
